Development of t(8;21) and RUNX1-RUNX1T1 in the Philadelphia-positive clone of a patient with chronic myelogenous leukemia: Additional evidence for multiple steps involved in disease progression

Vesna Najfeld, Nathaniel Wisch, John Mascarenhas, Leonard Issa, Joseph Tripodi, Manpreet Sidhu, Ronald Hoffman

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

A 65-year-old patient with a high hemoglobin and hematocrit was treated for 14 months with therapeutic phlebotomy when cytogenetics of bone marrow revealed 100% cells with the Ph chromosome and 45% of the Ph+ cells contained trisomy 8. Treatment with tyrosine kinase inhibitors did not reduce the BCR-ABL1 fusion positive clone. Instead, the Ph positive cells acquired further the t(8;21)/. RUNX1-RUNX1T1, del(4q) and trisomy 15 chromosomal abnormalities which were resistant to further treatment. Literature review revealed eight other patients who either had t(9;22) and t(8;21) simultaneously or developed t(8;21) in the Ph positive clone. We conclude that there are rare patients with CML who either present in blast crisis with coexistence of t(9;22) and t(8;21) with or without +8, or progress to blast crisis with acquiring RUNX1-RUNX1T1 in the BCR-ABL1 clone which may or may not be therapy related and represent a later event in a multistep pathogenesis.

Original languageEnglish
Pages (from-to)165-170
Number of pages6
JournalCancer genetics
Volume204
Issue number3
DOIs
StatePublished - Mar 2011

Keywords

  • AML
  • CML
  • Multistep pathogenesis
  • T(9;22)
  • t(8;21)

Fingerprint

Dive into the research topics of 'Development of t(8;21) and RUNX1-RUNX1T1 in the Philadelphia-positive clone of a patient with chronic myelogenous leukemia: Additional evidence for multiple steps involved in disease progression'. Together they form a unique fingerprint.

Cite this